Treatment and Management of Mild-to-Moderate Multiple Sclerosis

home / peer-exchange / treatment-and-management-of-mild-to-moderate-multiple-sclerosis

In a panel discussion, multiple sclerosis (MS) experts Stephen Krieger, MD; Heidi Crayton, MD; Jacqueline Nicholas, MD, PhD; Patricia Coyle, MD, and Enrique Alvarez, MD, PhD, share their insights on current MS therapies, aspirations for guideline revisions, the importance of shared decision-making, and the role of medium-efficacy therapy in the management of mild-to-moderate MS.

© 2024 MJH Life Sciences

All rights reserved.